Publicaciones en las que colabora con Rubén Andújar Espinosa (6)

2024

  1. Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study

    International Archives of Allergy and Immunology, Vol. 185, Núm. 3, pp. 253-259

2023

  1. Early Effectiveness of Dupilumab in Patients With Type 2 Severe Asthma: A Prospective Real-Life Study

    Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 2, pp. 126-128

2022

  1. Analysis of response of severe eosinophilic asthmatic patients to benralizumab

    Allergologia et Immunopathologia, Vol. 50, Núm. 6, pp. 163-168

  2. Effectiveness of Benralizumab in Severe Eosinophilic Asthma Under Conditions of Routine Clinical Practice

    Journal of Investigational Allergology and Clinical Immunology, Vol. 32, Núm. 3, pp. 220-223

  3. [Translated article] FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 5, pp. T442-T443

2021

  1. FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study

    Archivos de Bronconeumologia